Sinus bradycardia

Sinus bradycardia
Sinus bradycardia.
ICD-9	427.81
eMedicine	emerg/
MeSH	D001146

WikiDoc Resources for Sinus bradycardia
Articles
Most recent articles on Sinus bradycardia Most cited articles on Sinus bradycardia Review articles on Sinus bradycardia Articles on Sinus bradycardia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Sinus bradycardia Images of Sinus bradycardia Photos of Sinus bradycardia Podcasts & MP3s on Sinus bradycardia Videos on Sinus bradycardia
Evidence Based Medicine
Cochrane Collaboration on Sinus bradycardia Bandolier on Sinus bradycardia TRIP on Sinus bradycardia
Clinical Trials
Ongoing Trials on Sinus bradycardia at Clinical Trials.gov Trial results on Sinus bradycardia Clinical Trials on Sinus bradycardia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Sinus bradycardia NICE Guidance on Sinus bradycardia NHS PRODIGY Guidance FDA on Sinus bradycardia CDC on Sinus bradycardia
Books
Books on Sinus bradycardia
News
Sinus bradycardia in the news Be alerted to news on Sinus bradycardia News trends on Sinus bradycardia
Commentary
Blogs on Sinus bradycardia
Definitions
Definitions of Sinus bradycardia
Patient Resources / Community
Patient resources on Sinus bradycardia Discussion groups on Sinus bradycardia Patient Handouts on Sinus bradycardia Directions to Hospitals Treating Sinus bradycardia Risk calculators and risk factors for Sinus bradycardia
Healthcare Provider Resources
Symptoms of Sinus bradycardia Causes & Risk Factors for Sinus bradycardia Diagnostic studies for Sinus bradycardia Treatment of Sinus bradycardia
Continuing Medical Education (CME)
CME Programs on Sinus bradycardia
International
Sinus bradycardia en Espanol Sinus bradycardia en Francais
Business
Sinus bradycardia in the Marketplace Patents on Sinus bradycardia
Experimental / Informatics
List of terms related to Sinus bradycardia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Sinus bradycardia is a heart rhythm that originates from the sinus node and has a rate of under 60 beats per minute. Common causes include sick sinus syndrome and pharmacotherapy such as beta-blockers. Sinus bradycardia is not unexpected in highly trained athletes. It only requires treatment if the patient is symptomatic.

Pathosphysiology

This rhythm may be caused by one of the following:

• Increased vagal tone.
• Intrinsic disease of the SA node.
• An effect of drugs, such as the use of digitalis or beta-blockers.
• Sleep
• Sinus bradycardia is a normal finding in a healthy, well-conditioned athlete.

Differential Diagnosis of Causes of Sinus Bradycardia

In alphabetical order.

• Ambenonium
• Acetylcholine
• Alfentanil
• Amiodarone
• Amyloidosis
• Anorexia nervosa
• Atenolol
• Ativan
• Beta blocker
• Bethanechol
• Brucellosis
• Bupivacaine
• Calcium channel blocker
• Carotid sinus hypersensitivity
• Cardiac catheterization
• Cerebral edema
• Cervical spine injury
• Cilobradine
• Clonidine
• Congenital Heart Disease
• Corgard
• Coughing
• Cretinism
• Decompression sickness
• Deserpidine
• Diabetic autonomic neuropathy
• Digitalis
• Diltiazem
• Dimethyl sulfoxide (DMSO)
• Diptheria
• Distigmine
• Drugs
• Dysautonomia
• Electrocution
• Fentanyl
• Fetal distress
• Glaucoma
• Glioblastoma
• High altitude sickness
• Hypercalcemia
• Hypercapnia
• Hyperkalemia
• Hypermagnesemia
• Hypoglycemia
• Hypothermia
• Hypothyroidism
• Hypoxia
• Increased intracranial pressure
• Ivabradine
• Kwashiorkor
• Lidocaine
• Lilly of the valley
• Lithium
• Lofexidine
• Malnutrition
• Meningitis
• Micturition syncope
• Miller-Dieker syndrome
• Myocardial Infarction, particularly inferior MI
• Myocarditis
• Nausea
• Nadolol
• Neostigmine
• Nerve gas
• Organophosphates
• Paclitaxel
• Physical training, elite athlete status
• Physostigmine (Eserine / Antrilirium)
• Post-tussive syncope
• Procainamide (Procan-SR / Pronestyl)
• Propranolol
• Quinidine
• Reserpine
• Rheumatic fever
• Sepsis
• Sick Sinus Syndrome (SSS)
• Sleep apnea
• Sotalol (Betapace)
• Spinal cord injury
• Starvation
• Subarachnoid hemorrhage
• Sufentanil
• Suxamethonium
• Tight fitting neckwear
• Toluene
• Tumors of the neck
• Tumor lysis syndrome
• Typhoid Fever
• Vagal nerve stimulation
• Vagotonia
• Valsalva maneuver
• Vasovagal syncope
• Verapamil
• Vicodin
• Vomitting
• Yellow fever
• Zatebradine

Diagnosis

Symptoms

The decreased heart rate can cause a decreased cardiac output resulting in symptoms such as lightheadedness, dizziness, hypotension, vertigo, and syncope.

Sinus bradycardia may lead to no symptoms in a young athlete.

Signs

There may be a wide pulse pressure. If cardiac output is reduced, there may be signs of end organ hypoperfusion.

Laboratory Studies

TFTs should be checked Check electrolytes, Ca, Mg Hypoglycemia should be excluded Consider a toxicologic screen

ECG Characteristics

• Rate: Less than 60.
• Rhythm: Regular.
• P waves: Upright, consistent, and normal in morphology and duration.
• PR Interval: Between 0.12-0.20 seconds in duration.
• QRS complex: Less than 0.12 seconds in width, and consistent in morphology.
• Early repolarization is accentuated in the setting of sinus bradycardia

EKG Examples

• 
  Sinus bradycardia
• 
  Sinus bradycardia

Treatment

Acute Management

If a patient is symptomatic, intravenous access should be established. Atropine can be administered down an endotracheal tube or can be administered intravenously. The dose is 0.5-1 mg IV or ET q 3-5 min up to 3 mg total (0.04 mg/kg). The pediatric dosing is 0.02 mg/kg/dose IV, minimum of 0.1 mg. Isoproteronol (Isoprel) has been used in the past, but carries risks. Transcutaneous pacing can be undertaken while a temporary wire is being placed. Offending or exacerbating agents such as beta-blockers, calcium channel blockers or digitalis should be discontinued and underlying causes treated. Sleep apnea is a common cause and should be treated with weight loss and BiPAP. Continuous monitoring in the hospital is recommended.

Chronic Management

Asymptomatic sinus bradycardia requires no treatment. Patients with Sick Sinus Syndrome generally require a pacemaker.

ACC/AHA/HRS Guideline Recommendations for Pacemaker Implantation

Recommendations for Permanent Pacing in Sinus Node Dysfunction

Class I

1. Permanent pacemaker implantation is indicated for SND with documented symptomatic bradycardia, including frequent sinus pauses that produce symptoms.(Level of Evidence: C)

2. Permanent pacemaker implantation is indicated for symptomatic chronotropic incompetence. (Level of Evidence: C)

3. Permanent pacemaker implantation is indicated for symptomatic sinus bradycardia that results from required drug therapy for medical conditions. (Level of Evidence: C)

Class IIa

1. Permanent pacemaker implantation is reasonable for SND with heart rate less than 40 bpm when a clear association between significant symptoms consistent with bradycardia and the actual presence of bradycardia has not been documented. (Level of Evidence:C)

2. Permanent pacemaker implantation is reasonable for syncope of unexplained origin when clinically significant abnormalities of sinus node function are discovered or provoked in electrophysiological studies. (Level of Evidence: C)

Class IIb

1. Permanent pacemaker implantation may be considered in minimally symptomatic patients with chronic heart rate less than 40 bpm while awake. (Level of Evidence: C)

Class III

1. Permanent pacemaker implantation is not indicated for SND in asymptomatic patients. (Level of Evidence:C)

2. Permanent pacemaker implantation is not indicated for SND in patients for whom the symptoms suggestive of bradycardia have been clearly documented to occur in the absence of bradycardia. (Level of Evidence:C)

3. Permanent pacemaker implantation is not indicated for SND with symptomatic bradycardia due to nonessential drug therapy. (Level of Evidence: C)

See also

• Sinus tachycardia
• Long QT syndrome

Additional resources

• ECGpedia: Course for interpretation of ECG
• The whole ECG - A basic ECG primer
• 12-lead ECG library
• Simulation tool to demonstrate and study the relation between the electric activity of the heart and the ECG
• ECG information from Children's Hospital Heart Center, Seattle
• ECG Challenge from the ACC D2B Initiative
• National Heart, Lung, and Blood Institute, Diseases and Conditions Index
• A history of electrocardiography
• EKG Interpretations in infants and children

Template:WikiDoc Sources